The dopamine D2 and D3 receptors (D2R and D3R), both belonging to the D2-like receptor subfamily, represent the major targets for neuropsychiatric disorders such as schizophrenia, Parkinson’s disease (PD), and substance use disorders (SUDs) [3,4]. This evidence concerns the gene DRD2 and Parkinson disease.